Multivalent Carbonic Anhydrases Inhibitors - Université de Montpellier
Article Dans Une Revue International Journal of Molecular Sciences Année : 2019

Multivalent Carbonic Anhydrases Inhibitors

Résumé

Biomolecular recognition using a multivalent strategy has been successfully applied, this last decade on several biological targets, especially carbohydrate-processing enzymes, proteases, and phosphorylases. This strategy is based on the fact that multivalent interactions of several inhibitory binding units grafted on a presentation platform may enhance the binding affinity and selectivity. The zinc metalloenzymes carbonic anhydrases (CAs, EC 4.2.1.1) are considered as drug targets for several pathologies, and different inhibitors found clinical applications as diuretics, antiglaucoma agents, anticonvulsants, and anticancer agents/diagnostic tools. Their main drawback is related to the lack of isoform selectivity leading to serious side effects for all pathologies in which they are employed. Thus, the multivalent approach may open new opportunities in the drug design of innovative isoform-selective carbonic anhydrase inhibitors with biomedical applications.

Domaines

Chimie
Fichier principal
Vignette du fichier
ijms-20-05352.pdf (9.29 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03527051 , version 1 (12-07-2022)

Licence

Identifiants

Citer

Fabrizio Carta, Pascal Dumy, Claudiu Supuran, Jean‐yves Winum. Multivalent Carbonic Anhydrases Inhibitors. International Journal of Molecular Sciences, 2019, 20 (21), pp.5352. ⟨10.3390/ijms20215352⟩. ⟨hal-03527051⟩
44 Consultations
1 Téléchargements

Altmetric

Partager

More